Patent Oppositions in skin medications industry

Explore the competitive field of skin medications where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in skin medications technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the skin medications industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the skin medications industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 23, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Neutralization Of Inhibitory Pathways In LymphocytesINNATE PHARMAMay 13, 2026STRAWMAN
Pharmaceutical FormulationsARRAY BIOPHARMAMar 18, 2026HAMM & WITTKOPP
Methods And Compositions For Treating VitiligoCENTRE HOSPITALIER UNIVERSITAIRE DE NICESep 3, 2025HGF
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAApr 10, 2025NESTLE
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAMar 27, 2025ARLA FOODS AMBA
Methods For Enhancing Efficacy Of A Vaccine By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSMar 25, 2025HAMPTON KNOWLES
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025TEVA PHARMACEUTICALS
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSJan 31, 2025MAIWALD
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYJan 24, 2025MICHALSKI HTTERMANN & PARTNER
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJan 23, 2025SECERNA

To stay ahead in the competitive skin medications industry, companies are constantly innovating. Here are the top patents facing oppositions in the skin medications industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 23, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS10
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY8
Jul 10, 2024Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIA4
Jun 19, 2019Composition Comprising Hyaluronic Acid And MepivacaineTEOXANE3
May 1, 2024Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALS2
Dec 19, 2018Lactobacillus Rhamnosus Rht-3201 Conjugated To Polysaccharide Polymer Binder, And Use Thereof For Prevention Or Treatment Of Atopic DiseasesILDONG PHARMACEUTICAL2
Sep 13, 2023Lipopeptide Compositions And Related MethodsCUBIST PHARMACEUTICALS2
Aug 22, 2018Transdermal Compositions Comprising An Active Agent Layer And An Active Agent Conversion LayerTEIKOKU PHARMA USA2
Nov 18, 2020Combination Treatment For Atopic DermatitisMICREOS HUMAN HEALTH2
Jan 26, 2022Dosing Regimen For A Selective S1P1 Receptor AgonistACTELION PHARMACEUTICALS2